重新评估七月效应:30年证据显示结局无差异
该研究系统综述并荟萃分析了1989年以来关于七月效应的文献,共纳入113项研究,其中92项(81.4%)未发现七月效应。
要点
- 多数研究未发现七月效应,死亡率与主要并发症合并结果无差异。
- 对7种常见内、外科疾病再入院分析未显示七月效应。
- 建议重新考虑同类主题研究,转而关注系统层面因素。
核心结论
- 过去30年证据以阴性结果为主,提示应重新考虑是否需继续开展类似主题研究,并转向关注系统层面因素以改善效率与结局。
研究设计与样本
- 进一步分析全国再入院数据库7年数据,比较城市教学与非教学医院患者30天再入院,涵盖3种内科和4种外科疾病,采用风险调整 logistic 双重差分回归。
主要发现
- 共113项研究符合纳入标准,其中92项(81.4%)报告无七月效应证据。
- 死亡率合并比值比(95%置信区间)为1.01(0.98-1.05),主要并发症为1.01(0.99-1.04),均无七月效应证据,不同专科、国家及时间趋势均无差异。
临床怎么用
- 临床不应基于七月效应假设而调整患者收治或增加额外监管,应关注系统层面因素以优化患者结局。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to critically evaluate whether admission at the beginning versus end of the academic year is associated with increased risk of major adverse outcomes. SUMMARY BACKGROUND DATA: The hypothesis that the arrival of new residents and fellows is associated with increases in adverse patient outcomes has been the subject of numerous research studies since 1989. Methods: We conducted a systematic review and random-effects meta-analysis of July Effect studies published before December 20, 2019, looking for differences in mortality, major morbidity, and readmission. Given a paucity of studies reporting readmission, we further analyzed 7 years of data from the Nationwide Readmissions Database to assess for differences in 30-day readmission for US patients admitted to urban teaching versus nonteach-ing hospitals with 3 common medical (acute myocardial infarction, acute ischemic stroke, and pneumonia) and 4 surgical (elective coronary artery bypass graft surgery, elective colectomy, craniotomy, and hip fracture) conditions using risk-adjusted logistic difference-in-difference regression. RESULTS: A total of 113 studies met inclusion criteria; 92 (81.4%) reported no evidence of a July Effect. Among the remaining studies, results were mixed and commonly pointed toward system-level discrepancies in efficiency. Metaanalyses of mortality [odds ratio (95% confidence interval): 1.01 (0.98-1.05)] and major morbidity [1.01 (0.99-1.04)] demonstrated no evidence of a July Effect, no differences between specialties or countries, and no change in the effect over time. A total of 5.98 million patient encounters were assessed for readmission. No evidence of a July Effect on readmission was found for any of the 7 conditions. CONCLUSION: The preponderance of negative results over the past 30 years suggests that it might be time to reconsider the need for similarly-themed studies and instead focus on system-level factors to improve hospital efficiency and optimize patient outcomes.
引用
- Zogg CK, Metcalfe D, Sokas CM, et al. Reassessing the July Effect: 30 Years of Evidence Show No Difference in Outcomes. Ann Surg. 2021. PMID: 33914485. doi:10.1097/SLA.0000000000004805
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。